Cardiovascular pathology and intestinal microbiome relationship: potential targets of pharmacotherapy
Open Access
- 25 June 2023
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- Vol. 17 (9) , 137-143
Abstract
Связь сердечно-сосудистой патологии и микробиома кишечника: потенциальные мишени фармакотерапииKeywords
This publication has 66 references indexed in Scilit:
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell HomeostasisScience, 2013
- Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular RiskNew England Journal of Medicine, 2013
- Intestinal microbiota determine severity of myocardial infarction in ratsThe FASEB Journal, 2012
- Interleukin-17A Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Cardiomyocyte Apoptosis and Neutrophil InfiltrationJACC, 2012
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Human oral, gut, and plaque microbiota in patients with atherosclerosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight LossDiabetes, 2010
- Th17 Cells Facilitate the Humoral Immune Response in Patients with Acute Viral MyocarditisJournal of Clinical Immunology, 2009
- Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestineFEMS Microbiology Letters, 2009
- Enteroendocrine cells: a site of ‘taste’ in gastrointestinal chemosensingCurrent Opinion in Endocrinology, Diabetes and Obesity, 2008